Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Renalytix Plc (RENX) Share Price

Price 5.90p on 29-12-2025 at 14:25:10
Change 0.00p 0%
Buy 6.00p
Sell 5.80p
Last Trade: Sell 16,887.00 at 5.898p
Day's Volume: 458,887
Last Close: 5.90p
Open: 5.90p
ISIN: GB00BYWL4Y04
Day's Range 5.90p - 5.90p
52wk Range: 5.75p - 12.50p
Market Capitalisation: £25.78m
VWAP: 5.843903p
Shares in Issue: 437.02m

Renalytix Plc (RENX) Latest Trades

Buy/Sell Volume Trade Prc Trade Type Trade Time
Sell* 16,887 5.898p Ordinary
14:11:19 - 29-Dec-25
Sell* 353 5.898p Ordinary
13:14:47 - 29-Dec-25
Sell* 66,987 5.82p Ordinary
11:56:26 - 29-Dec-25
Buy* 41 5.99p Ordinary
11:44:50 - 29-Dec-25
Sell* 10,000 5.82p Ordinary
11:36:22 - 29-Dec-25
Sell* 160,479 5.85p Ordinary
10:29:19 - 29-Dec-25
Sell* 33,000 5.85p Ordinary
09:48:10 - 29-Dec-25
Sell* 18,000 5.82p Ordinary
09:15:30 - 29-Dec-25
Sell* 16,605 5.85p Ordinary
08:27:42 - 29-Dec-25
Sell* 100,000 5.8255p Ordinary
08:14:15 - 29-Dec-25
See more Renalytix Plc trades

Renalytix Plc (RENX) Share Price History

Time period:
to
Date Open High Low Close Volume
29th Dec 2025 (Mon) 5.90 5.90 5.90 5.90 458,887
26th Dec 2025 (Fri) 5.90 5.90 5.90 5.90 0
25th Dec 2025 (Thu) 5.90 5.90 5.90 5.90 0
24th Dec 2025 (Wed) 5.90 5.90 5.90 5.90 200,317
23rd Dec 2025 (Tue) 6.25 6.25 5.75 5.90 1,867,540
22nd Dec 2025 (Mon) 6.25 6.25 6.25 6.25 558,418
19th Dec 2025 (Fri) 6.25 6.25 6.25 6.25 44,840
18th Dec 2025 (Thu) 6.25 6.25 6.00 6.00 3,253,118
17th Dec 2025 (Wed) 6.25 6.25 6.25 6.25 637,515
16th Dec 2025 (Tue) 6.25 6.25 6.25 6.25 223,355
15th Dec 2025 (Mon) 6.25 6.25 6.25 6.25 431,431
12th Dec 2025 (Fri) 6.25 6.25 6.25 6.25 64,369
11th Dec 2025 (Thu) 6.25 6.25 6.25 6.25 98,386
10th Dec 2025 (Wed) 6.25 6.25 6.25 6.25 222,685
9th Dec 2025 (Tue) 6.75 6.75 6.25 6.25 2,827,141
8th Dec 2025 (Mon) 6.75 6.75 6.75 6.75 488,661
5th Dec 2025 (Fri) 6.75 6.75 6.75 6.75 271,219
4th Dec 2025 (Thu) 6.75 6.75 6.60 6.75 260,928
3rd Dec 2025 (Wed) 6.75 6.75 6.75 6.75 160,347
2nd Dec 2025 (Tue) 6.75 6.48 6.48 6.75 486,240
1st Dec 2025 (Mon) 6.75 6.75 6.75 6.75 0
See more Renalytix Plc price history

Renalytix Plc (RENX) Regulatory News

Date Source Headline
24th Dec 2025 12:56 pm RNS Holding(s) in Company
24th Dec 2025 12:56 pm RNS Holding(s) in Company
23rd Dec 2025 4:13 pm RNS Holding(s) in Company
23rd Dec 2025 4:13 pm RNS Holding(s) in Company
19th Dec 2025 12:18 pm RNS Holding(s) in Company
19th Dec 2025 12:18 pm RNS Holding(s) in Company
17th Dec 2025 1:42 pm RNS Holding(s) in Company
16th Dec 2025 1:51 pm RNS Holding(s) in Company
9th Dec 2025 10:57 am RNS Result of AGM
9th Dec 2025 7:00 am RNS AGM Statement
See more Renalytix Plc regulatory news

Renalytix Plc (RENX) Share News

AIM WINNERS & LOSERS: MediaZest expects full-year earnings boost

9th Dec 2025 10:24

(Alliance News) - The following stocks are the leading risers and fallers on AIM on Tuesday. Read More

IN BRIEF: Life Science REIT hires former Hipgnosis Songs Fund chair

3rd Dec 2025 12:11

Life Science REIT PLC - real estate investment trust for UK properties leased to tenants in the life science sector - Hires Robert Naylor to be senior independent director, starting on Wednesday. Naylor replaces Richard Howell as senior director, but Howell will remain a non-executive director. Naylor previously was chair of both Hipgnosis Songs Fund Ltd and peer Round Hill Music Royalty Fund Ltd. He currently is chair of Aquila European Renewables PLC and is a non-executive director of PRS REIT PLC, Niox Group PLC and Renalytix PLC. As an executive, Naylor is lead fund manager for Achilles Investment Co Ltd. He previously worked at JP Morgan Asset Management, Panmure Gordon and Cenkos Securities. Read More

IN BRIEF: Aquila European Renewables appoints Robert Naylor as chair

28th Nov 2025 16:10

Aquila European Renewables PLC - managed by Aquila Capital, invests in European renewable energy assets - Appoints Robert Naylor as non-executive chair, effective Friday this week. Confirms Non-Executive Chair Ian Nolan has retired from the board as of Thursday, having served in his role since prior to the IPO in 2019. Aquila highlights Naylor's 29 years of experience in capital markets, with him specialising in the investment trusts sector. Notes his current position as lead fund manager at Achilles Investment Company Ltd, and NED at PRS REIT PLC, Niox Group PLC and Renalytix PLC. Read More

TRADING UPDATES: Celsius raises funds; Built Cybernetics acquisition

12th Nov 2025 15:40

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Wednesday and not separately reported by Alliance News: Read More

IN BRIEF: Renalytix loss narrows as costs down amid fewer employees

3rd Nov 2025 12:20

Renalytix PLC - London-based diagnostics company - Pretax loss narrows to USD21.8 million in the financial year ended June 30, from USD45.5 million a year prior. Revenue climbs 30% to USD3.0 million from USD2.3 million, with the company citing revenue growth across all revenue streams, as well as additional integration with a large physician practice in New York and increased pharma services revenue from global pharma leaders. Administrative costs reduce by 40% to USD18.4 million from USD30.7 million. This was "driven by headcount and operations optimization, delisting from NASDAQ, and the regaining foreign private issuer status. While reorganisation and delisting costs were higher than anticipated, the resulting reduction has provided a lower, predictable cash burn profile." Looking ahead, Renalytix says it continued to strengthen its presence in its initial three target states of Florida, Texas and New York. The company expects to announce additional complimentary strategic agreements in the current financial year running til the end of June 2026. Read More

See more Renalytix Plc news
FTSE 100 Latest
Value9,884.84
Change14.16

Login to your account

Forgot Password?

Not Registered